Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LYRANASDAQ:MHUANASDAQ:OSRHOTCMKTS:VYCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLYRALyra Therapeutics$10.68+3.9%$8.25$3.81▼$37.50$14.15M-0.01187,997 shs116,783 shsMHUAMeihua International Medical Technologies$0.41+8.4%$0.37$0.25▼$1.47$13.08M0.85689,076 shs94,467 shsOSRHOSR$1.62+5.2%$1.34$1.02▼$13.40$31.23M1.61150,897 shs98,361 shsVYCOVycor Medical$0.12$0.12$0.03▼$0.50$3.84M-0.423,641 shs10 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLYRALyra Therapeutics0.00%-9.87%+121.58%+22.06%-17.47%MHUAMeihua International Medical Technologies0.00%+7.87%+6.69%+19.89%-51.49%OSRHOSR0.00%-0.61%+40.87%-5.26%+161,999,900.00%VYCOVycor Medical0.00%-2.44%-4.37%+77.54%+15.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLYRALyra Therapeutics3.0994 of 5 stars3.24.00.00.04.01.70.6MHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLYRALyra Therapeutics 2.33Hold$100.00836.33% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/AVYCOVycor Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLYRALyra Therapeutics$1.53M9.28N/AN/A$8.86 per share1.21MHUAMeihua International Medical Technologies$96.90M0.13$0.46 per share0.90$6.34 per share0.06OSRHOSRN/AN/AN/AN/AN/AN/AVYCOVycor Medical$1.59M2.42N/AN/A($0.11) per share-1.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/12/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/AOSRHOSRN/AN/A0.00∞N/AN/AN/AN/AN/AVYCOVycor Medical-$110KN/A0.00∞N/A-6.86%N/A-11.44%8/11/2025 (Estimated)Latest VYCO, LYRA, OSRH, and MHUA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025OSRHOSRN/A-$1.04N/A-$1.04N/A$0.76 million5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLYRALyra TherapeuticsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLYRALyra TherapeuticsN/A2.962.96MHUAMeihua International Medical TechnologiesN/A5.265.21OSRHOSRN/AN/AN/AVYCOVycor MedicalN/A0.130.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLYRALyra Therapeutics95.62%MHUAMeihua International Medical Technologies1.17%OSRHOSR55.30%VYCOVycor MedicalN/AInsider OwnershipCompanyInsider OwnershipLYRALyra Therapeutics3.25%MHUAMeihua International Medical Technologies66.56%OSRHOSR33.67%VYCOVycor Medical7.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableOSRHOSRN/A19.28 million12.79 millionN/AVYCOVycor Medical633.42 million31.07 millionNot OptionableVYCO, LYRA, OSRH, and MHUA HeadlinesRecent News About These CompaniesVYCO Vycor Medical, Inc.May 31, 2025 | seekingalpha.comVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comMedical ethics articles from across Nature PortfolioOctober 22, 2024 | nature.comBlueChew Review 2024January 17, 2024 | medicalnewstoday.comWhat to know about bleeding hemorrhoidsDecember 19, 2023 | medicalnewstoday.comCommon symptoms of depression: What to knowOctober 11, 2023 | medicalnewstoday.comVycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comMedical Scholars ProgramSeptember 12, 2022 | slu.eduVycor Medical IncSeptember 8, 2022 | reuters.comMinnetronix commercializes its own product: a minimally invasive deep brain access portAugust 20, 2022 | medcitynews.comViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMay 12, 2022 | nice.org.ukVycor Medical Year to Date Total Returns (Daily)January 2, 2022 | ycharts.comVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comThe journal of physical chemistry. BOctober 18, 2021 | medscape.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVYCO, LYRA, OSRH, and MHUA Company DescriptionsLyra Therapeutics NASDAQ:LYRA$10.68 +0.40 (+3.89%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$10.81 +0.13 (+1.25%) As of 06/18/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Meihua International Medical Technologies NASDAQ:MHUA$0.41 +0.03 (+8.44%) Closing price 06/18/2025 03:58 PM EasternExtended Trading$0.40 -0.01 (-2.66%) As of 06/18/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.OSR NASDAQ:OSRH$1.62 +0.08 (+5.19%) As of 06/18/2025 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Vycor Medical OTCMKTS:VYCO$0.12 0.00 (0.00%) As of 06/18/2025Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
